| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |